SI — Shoulder Innovations, Inc. stock price, charts and financials

QT79Shoulder Innovations, Inc.

Shoulder Innovations, Inc. (NYSE: SI) is a Healthcare company in the Medical - Specialties industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
20.82
+0.23+1.14%
OverviewShort InterestFilings
SIQT79Shoulder Innovations, Inc.·NYSE
20.82+1.14%
News
Up 1.1% — Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer (prnewswire.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Insider open-market saleHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
MOBI+8.33%$13.26MASS+2.03%$9.06STE-0.47%$236.35ALC+0.45%$72.13CRNX+0.18%$84.23SYRE+0.18%$105.10TEM+7.36%$55.88NUVL+0.00%$123.96
Snapshot
Index-P/E-EPS (ttm)-2.17Insider Own-Shs Outstand20.74MPerf Week-9.45%
Market Cap427.00MForward P/E-EPS next Y-1.31Insider Trans-1.53%Shs Float18.12MPerf Month-3.01%
Enterprise Value417.39MPEG0.76EPS next Q-0.46Inst Own-Short Float1.15%Perf Quarter61.24%
Income-35.06MP/S7.11EPS this Y21.10%Inst Trans-Short Ratio1.92Perf Half Y63.80%
Sales60.06MP/B3.43EPS next Y23.26%ROA-23.05%Short Interest208.43KPerf YTD43.99%
Book/sh-P/C-EPS next 5Y-ROE-24.36%52W High24.88 -16.30%Perf Year57.66%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-25.25%52W Low11.04 88.55%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin77.34%Volatility6.97% 6.61%Perf 5Y-
Dividend TTM-EV/Sales6.95EPS Y/Y TTM-181.82%Oper. Margin-58.53%ATR (14)1.50Perf 10Y-
Dividend Ex-Date-Quick Ratio8.92Sales Y/Y TTM68.75%Profit Margin-58.33%RSI (14)45.86Recom2.00
Dividend Gr. 3/5Y-Current Ratio10.71EPS Q/Q-115.42%SMA20-6.04%Beta0.34Target Price23.00
Payout0.00%Debt/Eq0.12Sales Q/Q70.00%SMA504.42%Rel Volume2.44Prev Close20.59
Employees75LT Debt/Eq0.10EarningsSep 08SMA20033.60%Avg Volume117.71KPrice20.82
IPO DateJul 31, 2025Option/ShortYes / YesEPS/Sales Surpr.-0.10% 14.94%Net Debt/EBITDA0.29Volume286,870Change1.14%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26InitiatedUBSBuy$27
May-08-26ReiteratedPiper SandlerOverweight$18 → $19
Dec-02-25ReiteratedMorgan StanleyOverweight$18 → $23
Aug-25-25InitiatedMorgan StanleyOverweight$13 → $18
Aug-25-25InitiatedJefferiesBuy$19
Aug-25-25InitiatedPiper SandlerOverweight$18
Aug-25-25InitiatedGoldman SachsBuy$10 → $20
Jan-09-23ReiteratedMorgan Stanley$24 → $13
Jan-09-23ReiteratedWedbush$45 → $9.00
Jan-09-23ReiteratedGoldman Sachs$35 → $10
Latest News
Today
Today07:00AM
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officerprnewswire.com
Aug-09-26
Aug-09-2602:06AM
Shoulder Innovations Q2 Earnings Call Highlightsmarketbeat.com
Aug-06-26
Aug-06-2610:18PM
Shoulder Innovations (NYSE:SI) Posts In-Line Q2 Results, Raises Full-Year OutlookChartMill
08:24PM
Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcriptseekingalpha.com
08:12PM
Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimateszacks.com
04:05PM
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlookprnewswire.com
Jul-29-26
Jul-29-2604:05PM
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conferenceprnewswire.com
05:33AM
UBS Initiates Coverage of Shoulder Innovations (SI) with Buy RecommendationFintel
Jul-27-26
Jul-27-2608:18PM
Silicon Metals Corp. Provides Corporate Updatenewsfilecorp.com
Jul-14-26
Jul-14-2604:05PM
Shoulder Innovations to Report Second Quarter 2026 Financial Results on August 6, 2026prnewswire.com
Jun-29-26
Jun-29-2607:00AM
Shoulder Innovations Announces Closing of up to $50 Million Credit Facilityprnewswire.com
Company

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue604732—
Cost of Goods Sold Incl. D&A14117—
Gross Profit463624—
Selling, General and Administrative Excl. Other695535—
Research and Development1284—
Other Operating Expense1-10—
Operating Income-35-26-15—
Interest Expense-101—
Unusual Expense
————
Non-Operating Income (Expense)-1-140—
Net Income Before Taxes-35-40-16—
Income Taxes
000—
Consolidated Net Income-35-40-16—
Net Income From Continuing Operations-35-40-16—
Net Income-35-40-16—
EPS (Recurring)-1.71-1.96-0.77—
EPS (Basic, Before Extraordinaries)-1.71-1.96-0.77—
EPS (Diluted)-1.71-1.96-0.77—
EBITDA-33-37-12—
Other After Tax Adjustments
————
Stock Option Compensation Expense
————
Price To Earnings Ratio
————
Price To Sales Ratio7.296.39——
Gross Margin76.6776.6075.00—
Operating Margin-58.33-55.32-46.88—
Net Margin-58.33-85.11-50.00—
Shares Outstanding212120—
Market Capitalization437300——
Operating Lease Expense
————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$26.24$21.93$17.63$13.33$9.02● Close Price0.00M2.92M5.84M8.76M11.68MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Gilde Healthcare Holding B.V.10% OwnerAug 06 '26Sale22.602,09547,3472,212,207Aug 07
Gilde Healthcare Holding B.V.10% OwnerAug 05 '26Sale22.647,338166,1322,214,302Aug 07
Gilde Healthcare Holding B.V.10% OwnerAug 04 '26Sale22.7799,8122,272,7192,221,640Aug 05
Gilde Healthcare Holding B.V.10% OwnerAug 03 '26Sale22.7110,751244,1552,321,452Aug 05
Gilde Healthcare Holding B.V.10% OwnerJul 31 '26Sale22.7320,034455,3732,332,203Aug 03
Gilde Healthcare Holding B.V.10% OwnerJul 30 '26Sale23.3628,245659,8032,352,237Aug 03
Ahearn Matthew FraserChief Operating OfficerJun 15 '26Sale18.844,14478,070269,176Jun 16
Ahearn Matthew FraserChief Operating OfficerJun 12 '26Sale18.6815,856296,185273,320Jun 16
Ball Robert JosephCEO & Executive ChairmanApr 30 '26Option Exercise2.4810,00024,804300,018Apr 30
Ahearn Matthew FraserChief Operating OfficerApr 20 '26Option Exercise2.7321,66459,170286,765Apr 21
BUCKMAN PAULDirectorMar 13 '26Option Exercise2.2645,606103,12165,710Mar 17
Buchholz RichardDirectorMar 13 '26Buy14.841,00014,84013,666Mar 17
Ball Robert JosephCEO & Executive ChairmanMar 13 '26Buy15.182,20033,392278,866Mar 17
Points Jeffrey S.Chief Financial OfficerMar 13 '26Buy15.002,00030,00070,785Mar 17
Points Jeffrey S.Chief Financial OfficerMar 13 '26Option Exercise2.4813,26432,90068,785Mar 17
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.